Antioxidants in peripheral arterial disease

Current Drug Targets

Volumn 4, Issue 8, 2003, Pages 651-655

  Violi, Francesco ^a   Loffredo, L ^a   Mancini, A ^b   Marcoccia, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ASL/Ospedale di Montefiascone   (Italy)

Author keywords

Antioxidants; Atherosclerosis; Oxidative stress; Peripheral arterial disease

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; C REACTIVE PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTERY DISEASE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL OBSERVATION; DIETARY INTAKE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; LIPID OXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; ARTERIAL OCCLUSIVE DISEASES; HUMANS; PERIPHERAL VASCULAR DISEASES;

EID: 0141988641     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450033490786     Document Type: Review

References (65)

1. Steinberg, D. (1997) J. Biol. Chem., 272, 20963-6.
2. Gerrity, R.G. (1981) Am. J. Pathol., 103, 181-90.
3. Gerrity, R.G. (1981) Am. J. Pathol., 103, 191-200.
4. Ross, R. N. (1976) Engl. J Med., 295, 369-77.
5. Brown, M.S.; Goldstein, J.L. (1983) Annu. Rev. Biochem., 52, 223-61.
6. Goldstein, J.L.; Ho, Y.K.; Basu, S.K.; Brown, M.S. (1979) Proc. Natl. Acad. Sci. USA, 76,333-7.
7. Kugiyama, K.; Kerns, S.A.; Morrisett, J.D.; Roberts, R.; Henry, P.D. (1990) Nature, 344, 160-2.
8. Frostegard, J.; Haegerstrand, A.; Gidlund, M.; Nilsson, (1991) J. Atherosclerosis, 90, 119-26.
9. Frostegard, J.; Nilsson, J.; Haegerstrand, A.; Hamsten, A.; Wigzell, H.; Gidlund, M. (1990) Proc. Natl. Acad. Sci. USA, 87,904-8.
10. Schmidt, K.; Graier, W.F.; Kostner, G.M.; Mayer, B.; Kukovetz, W. R. (1990) Biochem. Biophys. Res. Commun., 172, 614-9.
11. Weis, J.R.; Pitas, R.E.; Wilson, B.D.; Rodgers, G.M. (1991) FASEB J., 5, 2459-65.
12. Volf, I.; Roth, A.; Cooper, J.; Moeslinger, T.; Koller, E. (2000) FEBS Lett., 483, 155-9.
13. Cushing, S.D.; Berliner, J.A.; Valente, A.J.; Territo, M.C. ; Navab, M.; Parhami, F.; Gerrity, R.; Schwartz, C.J.; Fogelman, A.M. (1990) Proc. Natl. Acad. Sci. USA, 87, 5134-8.
14. Rajavashisth, T.B.; Andalibi, A.; Territo, M.C.; Berliner, J.A.; Navab, M.; Fogelman, A.M.; Lusis, A.J. (1990) Nature, 344, 254-7.
15. Praticò, D. F. (1999) Atherosclerosis, 147, 1-10.
16. Chisolm, G.M. Ma, G.; Irwin, K.C.; Martin, L.L.; Gunderson, K.G.; Linberg, L.F.; Morel, D.W.; DiCorleto, P.E. (1994) Proc. Natl. Acad. Sci. USA, 91,11452-6.
17. Brown, A.J.; Jessup, W. (1999) Atherosclerosis, 42, 1-28.
18. Liu,-Y.; Hulten, L.M.; Wiklund, O. (1997) Arterioscler. Thromb. Vasc. Biol., 17,317-23.
19. Jovinge, S.; Ares, M.P.; Kallin, B.; Nilsson, J. (1996) Arterioscler. Thromb. Vasc. Biol., 16, 1573-9.
20. Ku, G.; Thomas, C.E.; Akeson, A.L,.; Jackson, R.L. (1992) acid. J. Biol. Chem., 267, 14183-8.
21. Malden, L.T.; Chait, A.; Raines, E.W.; Ross, R. (1991) J. Biol. Chem., 266, 13901-7.
22. Esterbauer, H.; Gebicki, J.; Puhl, H.; Jurgens, G. (1992) Free Radic. Biol. Med, 13, 341-90.
23. Pryor, W.A. (2000) Free Radic. Biol. Med., 28,141-64.
24. Violi, F.; Micheletta, F.; Iuliano, L. Vitamin E, atherosclerosis and thrombosis. (2001) Thromb Haemostas, 85, 766-70.
25. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. (1992) Free Radic. Biol. Med, 13, 341-90.
26. Gey, K.F.; Puska, P.; Jordan, P.; Moser, U.K. (1991) Am. J. Clin. Nutr., 53,326S-334S.
27. Pryor, W.A. (2000) Free Radic. Biol. Med., 28(1),141-64.
28. Gey, K. F. Vitamin E and other essential antioxidants regarding coronary heart disease: risk assessment studies. Epidemiological basis of the antioxidant hypothesis of cardiovascular disease. In: Packer, L.; Fuchs, J., eds. Vitamin E in health and disease. New York, NY: Marcel Dekker, Inc.; 1993, 589-633.
29. Riemersma, R.A.; Wood, D.A.; Macintyre, C.C.; Elton, R.A.; Gey, K.F. Oliver, M.F. (1991) Lancet, 337, 1-5.
30. Mezzetti, A.; Zuliani, G.; Romano, F.; Costantim, F.; Pierdomenico, S.D.; Cuccurullo, F.; Fellin, R. (2001) J. Am. Geriatr. Soc., 49, 533-7.
31. Hodis, H.N.; Mack, W.J.; LaBree, L.; Mahrer, P.R.; Sevanian, A.; Liu, C.R.; Liu, C.H.; Hwang, J.; Selzer, R.H.; Azen, S.P. (2002) Circulation, 106, 1453-9.
32. Iuliano, L.; Mauriello, A.; Sbarigia, E.; Spagnoli, L.G.; Violi, F. (2000) Circulation, 101, 1249-54.
33. Stephens, N.G.; Parsons, A.; Schofield, P.M.; Kelly, F.; Cheeseman, K.; Mitchinson, M.J. (1996) Lancet, 347, 781-6.
34. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. (2000) N. Engl. J. Med, 342, 154-60.
35. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. (1999) Lancet, 354, 447-55.
36. Jialal, L; Devaraj, S. (2000) N. Engl. J. Med, 342, 1917-8.
37. Boaz, M.; Smetana, S.; Weinstein, T.; Matas, Z.; Gafter, U.; Iiana, A.; Knecht, A.; Weissgarten, Y.; Brunner, D.; Fainaru, M.; Green, M.S. (2000) Lancet, 356, 1213-8.
38. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. (2001) Lancet, 357, 89-95.
39. Tardif, J.C.; Cote, G.; Lesperance, J.; Bourassa, M.; Lambert, J.; Doucet, S.; Bilodeau, L.; Nattel, S.; de Guise, P. (1997) N. Engl. J Med, 337, 365-72.
40. Salonen, R.M.; Nyyssonen, K.; Kaikkonen, J.; Porkkala-Sarataho, E.; Voutilainen, S.; Rissanen, T.H.; Tuomainen, T.P.; Valkonen, V.P.; Ristonmaa, U.; Lakka, H.M.; Vanharanta, M.; Salonen, J.T.; Poulsen, H.E. (2000) J Intern. Med, 248, 377-86.
41. Lonn, E.; Yusuf, S.; Dzavik, V, Doris, C.; Yi, Q.; Smith, S.; Moore-Cox, A.; Bosch, J.; Riley, W.; Teo, K. (2001) Circulation, 103, 919-25.
42. Brown, B.G.; Zhao, X.Q.; Chait, A.; Fisher, L.D.; Cheung, M.C.; Morse, J.S.; Dowdy, A.A.; Marino, E.K.; Bolson, E.L.; Alaupovic, P.; Frohlich, J.; Albers, J.J. (2001) N. Engl. J. Med, 345, 1583-92.
43. Fang, J.C.; Kinlay, S. Beltrame, J.; Hikiti, H.; Wainstein, M.; Behrendt, D.; Suh, J.; Frei, B.; Mudge, G.H.; Selwyn, A.P.; Ganz, P. (2002) Lancet, 359, 1108-13.
44. Stephens, N.G.; Parsons, A.; Schofield, P.M.; Kelly, F. Cheeseman, K.; Mitchinson, M.J. (1996) Lancet, 347, 781-6.
45. Rapola, J.M.; Virtamo, J.; Ripatti, S.; Huttunen, J.K.; Albanes, D.; Taylor, P.R.; Heinonen, O.P. (1997) Lancet, 349, 1715-20.
46. Violi, F.; Micheletta, F.;Iuliano, L.; (2002) Lancet, 360(9347), 1782-3
47. GISSI-Prevenzione Investigators. (1999) Lancet, 354, 447-55.
48. Violi, F.; Micheletta, F.; Iuliano, L. (2000) Lancet, 357, 632-3.
49. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. (2000) N. Eng. J. Med, 342, 154-60.
50. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high risk individuals: a randomised placebo-controlled trial. (2002) Lancet, 360, 23-33.
51. Jha, P.; Flather, M; Lonn, E.; Farkouh, M.; Yusuf, S. (1995) Ann. Lntern. Med., 123, 860-72.
52. Iuliano, L.; Micheletta, F.; Maranghi, M.; Frati, G.; Diczfalusy, U.; Violi, F. (2001) Arterioscler. Thromb. Vasc. Biol., 21, E34-7.
53. Hiatt,W.R. (2001) N. Engl. J Med., 344(21), 1608-21.
54. Ross, R. (1999) N. Engl. J Med., 340(2), 115-26.
55. Blake, G.J.; Ridker, P.M. (2002) J Intern. Med., 252(4), 283-94.
56. Ridker, P.M. (2003) Circulation, 107(3), 363-9.
57. Ridker, P.M.; Cushman, M.; Stampfer, M.J.; Tracy, R.P.; Hennekens, C.H. (1998) Circulation, 97(5), 425-8.
58. Witztum,J.L.;Steinberg,D. (1991) J. Clin. Invest., 88(6), 1785-92.
59. Monaco, C.; Crea, F.; Niccoli, G.; Summaria, F.; Cianflone, D.; Bordone, R.; Bellomo, G.; Maseri, A. (2001) Eur. Heart J, 22(17), 1572-7.
60. Bergmark, C.; Wu, R.; de Faire, U.; Lefvert, A.K.; Swedenborg, J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL.
61. Langlois, M.; Duprez, D.; Delanghe, J.; De Buyzere, M.; Clement, D.L. (2001) Circulation, 103(14), 1863-8.
62. Jialal, I; Devaraj, S. (2003) Am. J. Cardiol., 91(2), 200-2.
63. Livingstone, P. D.; Jones, C (1958) Lancet, 2, 602-604
64. Haeger, K. (1974) Am. J. Clin. Nutr., 27, 1179-1181
65. Williams, H. T. G.; Fenna, D.; MacBeth, R. A. (1971) Surg. Gynecol. Obstet., 132, 662-666.